CD8A and primary progressive multiple sclerosis: van Puijfelik et al. report that not only B cells but also CD20dim CD4+ and not CD20dim CD8+ memory T cells are reduced in the cerebrospinal fluid of people with primary progressive multiple sclerosis after ocrelizumab-associated depletion of circulating B cells and CD20dim T cells.